Page last updated: 2024-08-26

selenium and osimertinib

selenium has been researched along with osimertinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chan, LS; Li, L; Li, MSC; Liu, J; Mok, TSK; Tao, Q	1

Other Studies

1 other study(ies) available for selenium and osimertinib

Article	Year
Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interference. Clinical epigenetics, 2023, 03-02, Volume: 15, Issue:1 Topics: DNA Methylation; Epigenesis, Genetic; ErbB Receptors; Humans; Lung Neoplasms; Mixed Function Oxygenases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Selenious Acid; Selenium	2023

Article

Year

Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interference.

Clinical epigenetics, 2023, 03-02, Volume: 15, Issue:1

Topics: DNA Methylation; Epigenesis, Genetic; ErbB Receptors; Humans; Lung Neoplasms; Mixed Function Oxygenases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Selenious Acid; Selenium

2023